TITLE

Management of Community-Acquired Respiratory Tract Infections

AUTHOR(S)
Remington, Jack S.
PUB. DATE
September 2004
SOURCE
Clinical Infectious Diseases;9/1/2004 Supplement, Vol. 39, pS141
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information about a symposium entitled "Treatment of Respiratory infections and innovative Solutions to the Evolving Problem of Resistance" that was held to address new challenges in the management of community-acquired respiratory tract infections (CARTIs) at the 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy on September 27, 2002, in San Diego, California. CARTIs are a major cause of morbidity and mortality in the U.S. Among the many contributing factors are the emergence of resistant respiratory pathogens, especially high-level and multidrug-resistant pathogens, and inappropriate antimicrobial use. In his presentation, Dr. Adolf W. Karchmer provided a historical perspective on the emergence of resistance by reviewing the results of several large surveillance studies, highlighting the most recent results of the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin. Patient compliance and the efficacy of the drug are crucial to the successful use of antimicrobials to treat CARTIs.
ACCESSION #
14159494

 

Related Articles

  • Telithromycin: Do we really need this antimicrobial? Fish, Douglas N. // American Journal of Health-System Pharmacy;5/1/2005, Vol. 62 Issue 9, p901 

    Comments on the effect of telithromycin in the treatment of respiratory tract infection. Usefulness of the antimicrobial against pathogens; Properties of the drug that contribute to its clinical and microbiological efficacy; Suggestion on the need to evaluate the pharmacodynamic characteristic...

  • Telithromycin: The first ketolide for the treatment of respiratory infections. Kasbekar, Nishaminy; Acharya, Pinak S. // American Journal of Health-System Pharmacy;5/1/2005, Vol. 62 Issue 9, p905 

    Purpose. The pharmacology, mechanisms of resistance, in vitro activity, clinical efficacy, pharmacokinetics, indications, adverse effects, dosage and administration, and place in therapy of telithromycin in the treatment of respiratory infections are reviewed. Summary. Telithromycin is the first...

  • Long-Term Antibiotic Treatment for Acne May Be Associated With Respiratory Infections.  // Dermatology Nursing;Jun2006, Vol. 18 Issue 3, p285 

    The article reports on the results of the study, conducted by researchers at the University of Pennsylvania Center for Education and Research in Therapeutics, on the long-term antibiotic treatment for acne. The study's primary findings implicate that long-term antibiotic treatment for acne may...

  • More acute RTls as GPs cut scripts. Wilkinson, Emma // Pulse;11/1/2004, Vol. 64 Issue 43, p12 

    Focuses on the causal link of between falling antibiotic prescriptions and the rising severity of respiratory illnesses in Great Britain. Assertion of the Specialist Advisory Committee on Antimicrobial Resistance that general practitioners should not start prescribing more antibiotics; Analysis...

  • Rapid painless diagnosis of viral respiratory infection. Ipp, M.; Carson, S.; Petric, M.; Parkin, P. C. // Archives of Disease in Childhood;May2002, Vol. 86 Issue 5, p372 

    Acute respiratory infection (ARI) is the commonest cause of illness in children. With the development of rapid viral diagnostic technologies and the availability of effective antiviral therapy, community physicians will be able to make more accurate treatment decisions and reduce unnecessary...

  • Upcoming Infectious Disease Activities.  // Emerging Infectious Diseases;Oct2004, Vol. 10 Issue 10, p1894 

    Offers information on several conferences and other events about infectious diseases to be held from October to November 2004, including the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy.

  • ICAAC Conference In San Francisco, September 27-30. James, John S. // AIDS Treatment News;7/1/2006, Issue 419, p6 

    The article focuses on the 46th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, California. The event, which features topics on antibiotics, but with significant AIDS presentations, is expected to bring about 12,000 people. For more information...

  • Antibacterial Activity of Crab Haemolymph on Clinical Pathogens. Veeruraj, A.; Ravichandran, S.; Kumar, G. Ramesh // Trends in Applied Sciences Research;Mar2008, Vol. 3 Issue 2, p174 

    The present investigation was taken up to study the antibacterial activity of haemolymph extracts from six different species of crabs (Scylla tranquebarica, S. serreta, Nanosesarma minutum, Neoepisesarma tetragonum, Metapograpsus maculatus and Macropthalmus depressus). Two positive controls...

  • Ozone and Ozonated Oils in Skin Diseases: A Review. Travagli, V.; Zanardi, I.; Valacchi, G.; Bocci, V. // Mediators of Inflammation;2010, Vol. 2010, p1 

    Although orthodox medicine has provided a variety of topical anti-infective agents, some of them have become scarcely effective owing to antibiotic- and chemotherapeutic-resistant pathogens. For more than a century, ozone has been known to be an excellent disinfectant that nevertheless had to be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics